Patricia Baré
Academia Nacional de Medicina
39 Papers
257 Citations
Patricia Baré is an academic researcher from Academia Nacional de Medicina. The author has contributed to research in topics: Medicine & Hepatitis C virus. The author has an hindex of 11, co-authored 33 publications. Previous affiliations of Patricia Baré include National Scientific and Technical Research Council.
Chat about Author
Papers
Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection
Alejandro Malbrán,Liliana Belmonte,Ruibal-Ares B,Patricia Baré,Ivana Massud,Cecilia Parodi,M. Felippo,Richard L. Hodinka,Kathleen A. Haines,Kim E. Nichols,María M. de Bracco +10 more
TL;DR: In this paper, the authors describe progressive changes observed in immunoglobulin concentrations, lymphocyte subsets, and Epstein-Barr virus (EBV) loads occurring in a 2-year period in a newly infected, but otherwise healthy, carrier.
57
Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients
Patricia Baré,Ivana Massud,Cecilia Parodi,Liliana Belmonte,Gabriel García,Marcelo de Campos Nebel,Marcelo Corti,Miguel de Tezanos Pinto,Raúl Pérez Bianco,Maria M.E. de Bracco,Rodolfo Hector Campos,Beatriz Ruibal Ares +11 more
TL;DR: Findings add further weight to the involvement of PBMCs in persistence of HCV infection and emphasize the role of B lymphocytes as HCV reservoirs.
56
High prevalence of infection with a single hepatitis C virus genotype in a small rural community of Argentina.
Gaston Picchio,Patricia Baré,Valeria Descalzi,María V. Bussy,Sonia M. Soria,María P. Raffa,Nancy E. Mazzencio,Silvina Etchehun,Juan A. Cámera,Donald E. Mosier,Federico G. Villamil +10 more
TL;DR: A large population‐based survey was conducted in O'Brien, a small rural town in Argentina to evaluate the prevalence of HCV in this community and found a relatively unusual high number of individuals with elevated alanine aminotransferase levels.
32
Reservoirs of HIV replication after successful combined antiretroviral treatment.
TL;DR: The mechanisms of HIV persistence and the methods that can be used to distinguish latent from covert HIV replication in different cell types will be discussed.
27
Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study.
TL;DR: In this paper, the authors evaluated the efficacy and safety of Nitazoxanide in reducing the SARS-COV 2 viral load within 7 days of treatment in respiratory samples from COVID-19-infected patients with mild to moderate disease, compared to placebo.